I am a breastfeeding mother and i want to know if it is safe to use MP 1727? Is MP 1727 safe for nursing mother and child? Does MP 1727 extracts into breast milk? Does MP 1727 has any long term or short term side effects on infants? Can MP 1727 influence milk supply or can MP 1727 decrease milk supply in lactating mothers?
Information in this record refers to the use of MP 1727 as a diagnostic agent. The International Commission on Radiological Protection states that breastfeeding need not be interrupted following diagnostic use of In 111 pentetreotide.[1] In some cases, imaging with MP 1727 is followed shortly by a therapy (peptide receptor radiotherapy; PRRT) that uses yttrium 90 or lutetium 177 compounds to selectively irradiate tumors. These agents may pose additional radiation risk to the nursing infant. Mothers concerned about the level of radioactivity in their milk could ask to have it tested at a nuclear medicine facility at their hospital. When the radioactivity is at a safe level she may resume breastfeeding. A method for measuring milk radioactivity and determining the time when a mother can safely resume breastfeeding has been published.[2]
Disclaimer:
Information presented in this database is not meant as a substitute for professional judgment. You should consult your healthcare provider for breastfeeding advice related to your particular situation. We do not warrant or assume any liability or responsibility for the accuracy or completeness of the information on this Site.